For diagnosing acute and chronic HF, according to the guidelines of the ACCF/AHA/ESC, BNP and NT-proBNP are considered to be the most valuable and reliable biomarkers, with proportional increase to the severity of the disease giving information about HF prognosis [141,144,145,146]. This evidence concerns the gene NPPB and hydrops fetalis.